Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Winghan Jacqueline Kwong, PharmD, PhD
Authored Items
Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization
Allison Petrilla, MPH
,
Atheer A. Kaddis, PharmD
,
Elizabeth Marrett, MPH
,
Xian Shen, PhD, MS, BS
,
Winghan Jacqueline Kwong, PharmD, PhD
,
Edmund Pezalla, MD, MPH
February 2020 Vol 13, No 1
in
Business
,
Original Research
Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia
F. Randy Vogenberg, PhD, FASHP
,
Craig White, PhD
,
Winghan Jacqueline Kwong, PharmD, PhD
,
Hilary Armstrong, PhD
,
Michael Behling
,
Jeffrey Niemira
,
Kathy Lang, PhD
September 2018 Vol 11, No 6
in
Clinical
,
Original Research
Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting
Jennifer Cai, MS, MPH
,
Winghan Jacqueline Kwong, PharmD, PhD
,
Ronald Preblick, PharmD, MPH
,
Qiaoyi Zhang, MD, PhD
,
James T. Kenney, RPh, MBA
November 2014 Vol 7, No 8
in
Clinical
The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis
Kathryn Fitch, RN, MEd
,
Raymond L. Singer, MD, MMM, CPE
,
Jonah Broulette, ASA, MAAA
,
Winghan Jacqueline Kwong, PharmD, PhD
June 2014 Vol 7, No 4
in
Business
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Delete Delete
,
Jonah Broulette
,
Bruce S. Pyenson, FSA, MAAA
,
Kosuke Iwasaki, FIAJ, MAAA
,
Winghan Jacqueline Kwong, PharmD, PhD
,
Michael F. Murphy, MD, PhD
May/June 2012, Vol 5, No 3
in
Business
Last modified: April 11, 2019